
About OVAX
OVAX is a company based in Houston (United States) founded in 2023 by Colin Haile, Ofer Levy, JR Rahn, and Collin Gage. It operates as a B2B. OVAX offers products and services including Protective Therapeutic and ARMR OS. OVAX operates in a competitive market with competitors including IgGenix, Mithradote Bio, Globin Solutions, metaLead Therapeutics and Kaival Labs, among others.
Products & Services of OVAX
OVAX offers a comprehensive portfolio of products and services, including Protective Therapeutic and ARMR OS.
Biotech solution that produces antibodies to neutralize fentanyl
AI platform for real-time tracking and prediction of drug threats
People of OVAX
4 people are tracked at OVAX (4 in leadership).
| Name | Role | Group |
|---|---|---|
Colin Haile | Co-Founder | Leadership |
Ofer Levy | Co-Founder | Leadership |
JR Rahn | Co-Founder | Leadership |
Collin Gage | Co-Founder, CEO | Leadership |
Complete people profiles for OVAX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of OVAX
OVAX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IgGenix, Mithradote Bio, Globin Solutions, metaLead Therapeutics and Kaival Labs, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| iggenix.com | 2019 | San Francisco, United States | $75M | – | Therapeutic solutions for food allergies are developed via antibody platforms. | |
| mithradote.com | 2023 | San Diego, United States | $1M | – | Medication is provided to prevent drug-facilitated sexual assault. | |
| globinsolutions.com | 2017 | Pittsburgh, United States | $5M | – | Antidotal therapies for human poisonings are developed using neuroglobin technology. | |
| metaleadtherapeutics.tcc.mode | 2022 | Zurich, Switzerland | $170,018 | – | Next-generation medications against metal poisoning are developed. | |
| kaivallabs.com | 2019 | Palm Bay, United States | – | – | Develops innovative technologies for nicotine addiction treatment. | |
| sobrera.com | 2019 | Gothenburg, Sweden | – | – | Drugs for alcohol use disorders are developed by Sobrera. | |
| alarpharm.com | 2016 | Taichung, Taiwan | – | – | Drugs for opioid use disorder and depressive disorder are developed. | |
| junhemeng.tcc.mode | 2020 | Hangzhou, China | – | – | Recombinant protein drugs are developed for toxicity and metabolic diseases. | |
| temperobio.com | 2020 | Oakland, United States | $70M | – | Therapeutics for substance use disorders, including opioid-related conditions, are developed. |
Detailed competitors of OVAX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to OVAX
10 companies that operate in the same segment as OVAX (Toxicology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | – | – | |
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | – | – | |
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 | |
Non-invasive drug testing technology is developed using fingerprints. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 25.71 M | – | – | |
Provides toxicology, chemistry, and consultancy services for agrochemical industries. | 2020 | Vapi, Gujarat, India | – | – | – | |
Instruments for rapid human DNA identification are developed. | 2006 | Pleasanton, California, United States | USD 92.06 M | USD 22.5 B | 78 | |
Oral therapies for snake bite treatment are developed. | 2015 | Corte Madera, California, United States | USD 16.48 M | – | – | |
Quantitative urine drug testing is provided for patient monitoring. | 2011 | San Diego, California, United States | – | – | 358 | |
Point-of-care platforms for heavy metal toxicity diagnostics are developed. | 1968 | Billerica, Massachusetts, United States | USD 34 M | – | – | |
Real-time trace gas analysis solutions are delivered using SIFT-MS technology. | 2002 | Christchurch, New Zealand | USD 11.9 M | USD 23.52 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OVAX
OVAX was founded in 2023.
OVAX is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Collin Gage is the current CEO of OVAX. They have also founded this company.
ARMR Sciences focuses on creating innovative biotech and AI technologies to combat fentanyl overdoses. Their biotech division develops protective therapeutics that produce antibodies to neutralize fentanyl in the bloodstream before it reaches the brain. The AI division builds systems for real-time tracking and prediction of drug threats, including decentralized warning networks. Based in the United States, they collaborate with partners to enhance public health and reduce overdose deaths through research and innovation.
OVAX's top competitors include IgGenix, Tempero Bio and Mithradote Bio.
OVAX offers Protective Therapeutic and ARMR OS.
OVAX operates through Armr Sciences Inc..